Literature DB >> 9724172

Effect of heparin on dextran sulfate sodium-induced colitis.

J R Korzenik1, A Hsu, M E Robert.   

Abstract

Heparin has been shown to ameliorate inflammatory bowel disease in several series. In addition to its anticoagulant properties, heparin has numerous other effects that may be beneficial in inflammatory bowel disease. Other sulfated polysaccharides, such as dextran sulfate, cause colitis in mice through unknown mechanisms. We postulate that dextran sulfate and heparin may act via similar pathways with opposite effects. To examine this thesis, the effect of heparin on dextran sulfate-induced colitis was studied. Swiss-Webster mice were given 5% dextran sulfate in their drinking water for five days to induce colitis. Heparin was given both therapeutically after the induction of colitis and prophylactically by subcutaneous injections, with saline injections given in controls. Histologic sections of colon were randomized and graded for colitis. Heparinized animals showed no significant difference in the pattern or severity of colitis when compared to control animals. It is concluded that heparin does not ameliorate the murine colitis induced by dextran sulfate in the doses given.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724172     DOI: 10.1023/a:1018800207063

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

Review 1.  Experimental colitis in animal models.

Authors:  H S Kim; A Berstad
Journal:  Scand J Gastroenterol       Date:  1992-07       Impact factor: 2.423

2.  Synergistic action of heparin and serum on basic fibroblast growth factor-modulated DNA synthesis and mitochondrial activity of cultured bovine corneal endothelial cells.

Authors:  V P Hoppenreijs; E Pels; P C Felten; J M Ruijter; G F Vrensen; W F Treffers
Journal:  Cornea       Date:  1996-07       Impact factor: 2.651

3.  Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice.

Authors:  L G Axelsson; E Landström; T J Goldschmidt; A Grönberg; A C Bylund-Fellenius
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

Review 4.  Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor.

Authors:  I Vlodavsky; H Q Miao; B Medalion; P Danagher; D Ron
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

5.  Paradoxical response to heparin in 10 patients with ulcerative colitis.

Authors:  P R Gaffney; C T Doyle; A Gaffney; J Hogan; D P Hayes; P Annis
Journal:  Am J Gastroenterol       Date:  1995-02       Impact factor: 10.864

6.  The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts.

Authors:  A V Ferrao; R M Mason
Journal:  Biochim Biophys Acta       Date:  1993-01-22

7.  Carrageenans inhibit growth-factor binding.

Authors:  R Hoffman
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

8.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

9.  Inhibition of binding of basic fibroblast growth factor to low and high affinity receptors by carrageenans.

Authors:  R Hoffman; D Sykes
Journal:  Biochem Pharmacol       Date:  1993-06-09       Impact factor: 5.858

10.  Effect of exogenous heparin on anchorage-independent growth of fibroblasts induced by transforming cytokines.

Authors:  R E Hurst; R L Bynum; S W Rhodes
Journal:  Cancer Lett       Date:  1993-05-14       Impact factor: 8.679

View more
  4 in total

1.  Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.

Authors:  S Kishimoto; K Haruma; A Tari; K Sakurai; M Nakano; Y Nakagawa
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.

Authors:  Sheng-Li Ji; Hui-Fei Cui; Feng Shi; Yan-Qing Chi; Ji-Chao Cao; Mei-Yu Geng; Hua-Shi Guan
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

3.  Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat.

Authors:  Giuseppe Celasco; Luigi Moro; Roberta Bozzella; Katia Mangano; Cinzia Quattrocchi; Caterina Aiello; Marco Donia; Paolo Fagone; Roberto Di Marco
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

4.  Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses.

Authors:  Qi Ying Lean; Rajaraman D Eri; Sarron Randall-Demllo; Sukhwinder Singh Sohal; Niall Stewart; Gregory M Peterson; Nuri Gueven; Rahul P Patel
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.